RaySearch and Mevion extend collaboration to support advanced HYPERSCAN treatment planning capabilities
Two of the leaders in the field of proton therapy, Mevion Medical Systems and RaySearch Laboratories AB (publ), have collaborated since 2014. The companies are now strengthening their strategic collaboration effort to further advance capabilities with Mevion’s HYPERSCAN® proton therapy system and the unique Adaptive Aperture® proton multi-leaf collimator (pMLC) in the treatment planning system RayStation®*.In 2018, Mevion and RaySearch’s collaborative partnership enabled the layer-by-layer collimation with the Adaptive Aperture pMLC as part of the RayStation 8B release, leading to the first-